4.6 Article

Comparative analysis of patients with upper urinary tract urothelial carcinoma in black-foot disease endemic and non-endemic area

Related references

Note: Only part of the references are listed.
Article Oncology

Lung, Bladder, and Kidney Cancer Mortality 40 Years After Arsenic Exposure Reduction

Allan H Smith et al.

JNCI-Journal of the National Cancer Institute (2017)

Article Oncology

Lung, Bladder, and Kidney Cancer Mortality 40 Years After Arsenic Exposure Reduction

Allan H Smith et al.

JNCI-Journal of the National Cancer Institute (2017)

Article Urology & Nephrology

Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma

Shahrokh F. Shariat et al.

WORLD JOURNAL OF UROLOGY (2011)

Article Pharmacology & Pharmacy

Arsenic-induced bladder cancer in an animal model

Samuel M. Cohen et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)

Article Environmental Sciences

Arsenic cancer risk confounder in southwest Taiwan data set

Steven H. Lamm et al.

ENVIRONMENTAL HEALTH PERSPECTIVES (2006)

Article Substance Abuse

Smoking behaviour in Taiwan, 2001

CP Wen et al.

TOBACCO CONTROL (2005)

Review Pharmacology & Pharmacy

Arsenic toxicity at low doses:: epidemiological and mode of action considerations

A Schoen et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)

Article Urology & Nephrology

Upper tract urothelial neoplasms: Incidence and survival during the last 2 decades

JJ Munoz et al.

JOURNAL OF UROLOGY (2000)

Article Pharmacology & Pharmacy

Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes

JS Petrick et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2000)